Maggio I, et al. The functioning side of the pancreas: a review on insulinomas. J Endocrinol Invest. 2020;43(2):139–48.
Article CAS PubMed Google Scholar
Jinga M. et al. Diagnostic and treatment difficulties in insulinomas. Romanian J Military Med. 2015.
Johnsson S. Clinical significance of hypoglycemia, with presentation of cases. 2017.
Guilmette JM, Nosé V. Neoplasms of the neuroendocrine pancreas: an update in the classification, definition, and molecular genetic advances. Adv Anat Pathol. 2019;26(1):13–30.
Article CAS PubMed Google Scholar
Wei J, et al. Diagnosis and surgical management of insulinomas in 33 consecutive patients at a single institution. Langenbecks Arch Surg. 2016;401(7):1019–25.
Magi L, et al. Management of functional pancreatic neuroendocrine neoplasms. Curr Treat Options Oncol. 2023;24(7):725–41.
Article PubMed PubMed Central Google Scholar
Kouvaraki MA, et al. Surgical treatment of non-functioning pancreatic islet cell tumors. J Surg Oncol. 2005;89(3):170–85.
Meur G, et al. Insulin gene mutations resulting in early-onset diabetes: marked differences in clinical presentation, metabolic status, and pathogenic effect through endoplasmic reticulum retention. Diabetes. 2010;59(3):653–61.
Article CAS PubMed Google Scholar
Hong X, et al. Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification system. Gut. 2020;69(5):877–87.
Article CAS PubMed Google Scholar
Jyotsna VP, et al. Novel MEN 1 gene findings in rare sporadic insulinoma—a case control study. BMC Endocr Disord. 2015;15(1):44.
Article PubMed PubMed Central Google Scholar
Song Y-L, et al. Mutation and expression of gene YY1 in pancreatic neuroendocrine tumors and its clinical significance. Endocr Pract. 2021;27(9):874–80.
Burns L et al. Report of a novel molecular profile in malignant insulinoma. J Clin Med, 2023;12(4).
Teng J-H, et al. A rare case report of reversible glucose counterregulation in an insulinoma patient with type 2 diabetes. Endocrine. 2024;84(3):885–9.
Article CAS PubMed PubMed Central Google Scholar
AlJadir SJ. Insulinoma: literature’s review (Part 1). Endocrinol Metabolism Int J 2015;2.
Zhang C, Zhang H, Huang W. Endogenous hyperinsulinemic hypoglycemia: case series and literature review. Endocrine. 2023;80(1):40–6.
Article CAS PubMed Google Scholar
Yuniarti R, Auline S. Insulinoma. Jurnal RSMH Palembang. 2020;1(3):78–85.
Vanderveen K, Grant C. Insulinoma. Cancer Treat Res. 2010;153:235–52.
Vig S, et al. Lessons to be learned: a case study approach insulinoma presenting as a change in personality. J R Soc Promot Health. 2001;121(1):56–61.
Article CAS PubMed Google Scholar
Christ E, et al. Innovative imaging of insulinoma: the end of sampling? A review. Endocr Relat Cancer. 2020;27(4):R79-r92.
Article CAS PubMed PubMed Central Google Scholar
Hirsch IB, et al. The evolution of insulin and how it informs therapy and treatment choices. Endocr Rev. 2020;41(5):733–55.
Article PubMed PubMed Central Google Scholar
Garrido S, et al. Insulinoma in a patient with type 2 diabetes: a case report. AACE Clin Case Rep. 2016;2(4):e342–5.
Ghafoori S, Lankarani M. Insulinoma in a patient with type 2 diabetes mellitus. Acta Med Iran. 2015;53(5):317–9.
Mishra A et al. Outcome of pre-operative vs intraoperative localization techniques in insulinoma: experience in a tertiary referral center. Indian J Surg, 2022.
Singbo J, Locketz M, Ross IL. Challenge of coexisting type 2 diabetes mellitus and insulinoma: a case report. J Med Case Rep. 2021;15(1):479.
Article PubMed PubMed Central Google Scholar
Christ E, Wild D, Ederer S, Behe M, Nicolas G, Caplin ME, et al. Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study. Lancet Diabetes Endocrinol. 2013;1(2):115–22.
Comments (0)